HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR ‘Watchdog’ Women’s Voices For The Earth To Remain On Guard In 2021

Executive Summary

NGO says the Expert Panel for Cosmetic Ingredient Safety’s conclusion on methylisothiazolinone in 2020 was among decisions “not in the interest of public health.” However, other assessments highlighted by the group suggest that the Cosmetic Ingredient Review is working as an open forum for public input and discussion.

You may also be interested in...



WVE Declares Summer’s Eve Victory, Still Calling For ‘Radical Transformation’ Of Fem Care

After years of campaigning, Women’s Voices for the Earth is pleased by Summer’s Eve’s apparent reformulation of feminine cleaning products to remove ingredients of concern. But the NGO’s larger complaint pertains to the overall intimate-care category and its marketing.

PCPC Leadership On US Legislative Landscape, EU Microplastic Restriction, Other 2021 Concerns

The Personal Care Products Council’s government affairs heads, chief scientist and executive VP of global strategies discuss the trade association’s 2021 priorities and preoccupations.

CIR Expert Panel Reaches Tentative Decision On Benzophenones, Final On Methylisothiazolinone

At its 14-15 September virtual meeting, the Cosmetic Ingredient Review’s Expert Panel issued five final ingredient reports, four tentative reports, and insufficient data announcements for seven ingredients or ingredient groups, including silicates and 60 red algae ingredients.

Related Content

Topics

UsernamePublicRestriction

Register

RS151044

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel